• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. ADVANTIM DURAMER POST STAB TIBIAL INSERT LG/LG+; KNEE COMPONENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT ORTHOPEDICS INC. ADVANTIM DURAMER POST STAB TIBIAL INSERT LG/LG+; KNEE COMPONENT Back to Search Results
Model Number 18903310
Health Effect - Clinical Code Pain (1994)
Type of Reportable Event Serious Injury
Event or Problem Description
Allegedly, the patient was revised due to chronic knee pain, loosening of stem and components.(left knee).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANTIM DURAMER POST STAB TIBIAL INSERT LG/LG+
Common Device Name
KNEE COMPONENT
Manufacturer (Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
MDR Report Key11195307
Report Number3010536692-2021-00021
Device Sequence Number13629129
Product Code JWH
UDI-Device IdentifierM684189033101
UDI-PublicM684189033101
Combination Product (Y/N)N
Initial Reporter StateUT
Initial Reporter CountryUS
PMA/510(K) Number
K940235
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year1996
Device Explanted Year2006
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source distributor
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 01/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number18903310
Device Catalogue Number18903310
Device Lot Number114A009437
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date12/29/2020
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/29/2020
Initial Report FDA Received Date01/19/2021
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age59 YR
-
-